CANCER Q AND A: COLORECTAL CANCER EDITION — CME/CNE INFORMATION

STATEMENT OF NEED/TARGET AUDIENCE

Counseling patients on the adjuvant treatment options and personal implications of the diagnosis of early colorectal cancer is complex and time consuming. The many variants of this disease make it a challenge to explain important information to patients in an understandable manner.

This audio activity focuses on interviews with clinical and research specialists in colorectal cancer and specifically reviews how these clinicians educate and counsel their patients. In addition, this program provides interviews with patients and their spouses to illustrate the patient’s experience. The goal of this series is to help physicians and nurses better understand how to optimally discuss adjuvant therapy of colorectal cancer with patients in their care.

PURPOSE STATEMENT

To present the most current research developments and systemic adjuvant therapy options in early colorectal cancer, the perspectives of clinicians on how to present this information to patients and the experience of patients diagnosed with early colorectal cancer.

GLOBAL LEARNING OBJECTIVES

• Discuss the diagnosis and staging of early colorectal cancer, the risk of recurrence and the rationale for adjuvant therapy.
• Describe treatment options and clinical trials in the adjuvant setting for patients with colorectal cancer.
• Discuss side effects and benefits of various systemic adjuvant therapies for colorectal cancer.
• Describe potential benefits and risks to patients associated with clinical trial participation.
• Identify behavioral changes patients can employ to reduce their risk of recurrence.
• Describe the psychosocial and emotional impact associated with the diagnosis and treatment of early colorectal cancer on patients and their loved ones.
• Discuss the Patient Perspectives on Adjuvant Systemic Therapy of Early Colorectal Cancer survey and the implications for clinicians.

ACCREDITATION/CREDIT DESIGNATION STATEMENT

Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Research To Practice designates this educational activity for a maximum of 7.3 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Research To Practice is an approved provider of continuing nursing education by the New Jersey State Nurses Association, Provider Number P215-01/07-10. NJSNA is accredited by the ANCC Commission on Accreditation. Provider Approval is valid through January 31, 2010. This educational activity for 7.3 contact hours is provided by Research To Practice during the period of June 2007 through June 2008.

HOW TO USE THIS CME/CNE ACTIVITY

This activity contains both audio and print components, as well as corresponding PowerPoint slides on the enclosed CD. To receive credit, the clinician should listen to the six audio CDs, review the monograph and complete the Post-test and Evaluation Form on our website, www.CancerQandA.com. In addition, appropriately selected patients can use part or all of the materials contained on the five patient CDs. The participant can distribute copies of the audio discs or direct patients to download the MP3 files or read the transcripts at www.CancerQandA.com. The transcripts of these programs are included on the audio CDs. Kindly let us know whether this experiment in patient education works and how we can make it better. We welcome any feedback or questions to Info@ResearchToPractice.com.

This program is supported by an education grant from Sanofi-Aventis.

 

Table of Contents

Top of Page